In the present study, we prospectively examined the safety and efficacy of GRNX as a prophylactic antibiotic for the patients with hematological malignancies and showed... (a)

This would help communicate to markets how it is that the purchase program is consistent with a steady state with inflation at target and output at potential.. This would

The current study, in which piperacillin/tazobactam was administered as a bolus dose every 6 h, confirmed that the C min , elimination rate (Ke), and t 1/2 parameters

Keywords: bloodstream infection, fungemia, bacteremia, carbapenem resistance, azole resis- tance, antifungal treatment, hematological malignancies, febrile

Despite the comprehensive suite of legislation now implemented within Europe, the ubiquitous use of chemicals in society represents a major challenge with respect to the

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.

Coronation Domestic Absolute Portfolio 0.60% Performance fee: 15% of outperformance over CPI + 5% over rolling 36 month period capped at 1.4% per annum LIFE Coronation Life

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic

The Phylogenies analysis and enzymatic properties showed that the Tth xynB3 β -xylosidase was distant with the xylose-tolerant β -xylosidase from Paecilomyces thermophila

Hindawi Publishing Corporation EURASIP Journal on Wireless Communications and Networking Volume 2009, Article ID 623537, 12 pages doi 10 1155/2009/623537 Research Article Discrete

The larger observational study, including 190 patients treated with empirical antifungal therapy (neutropenic patients with fever without known source of infection and unresponsive

Neutropenia, Febrile neutropenia, FN call, Emergency Department Febrile Neutropenia, Patient Management, High risk Febrile Neutropenia Patient Management, Low risk Febrile

A systematic search was undertaken to identify randomised controlled trials (RCTs) of pegfilgrastim, filgrastim or lenograstim, com- pared with no primary G-CSF or with one another,

Patients were $ 18 years of age with a solid tumor or a malignant hematological tumor, had been prescribed cyto- toxic chemotherapy, and were starting primary prophylactic

with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. Pinto L, Liu Z, Doan Q:

Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5

4.2 Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related